Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Study ID: NCT07055295
Start Date: 2026-03-01
End Date: 2026-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

390

Intervention / Treatment

Rabies Vaccine (Serum-free Vero Cell), Freeze-dried

Verorab®

Sponsor

Sinovac Biotech Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

VEL-101 to Prevent Rejection After Kidney Transplantation

Study ID: NCT07290777
Start Date: 2026-07
End Date: 2028-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Tacrolimus (TAC)

WELL-101

Sponsor

Veloxis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage

Study ID: NCT07054801
Start Date: 2026-03-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Lidocaine hydrochloride

Methylprednisolone sodium succinate

Sponsor

Daniel Raper, MBBS

Source: clinicaltrials.gov

Share:
Add to list

Endoscopic Sleeve Gastroplasty Technique Comparison for Weight Loss

Study ID: NCT06299644
Start Date: 2026-09
End Date: 2028-05
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Endoscopic Sleeve Gastroplasty - Belt and Suspenders

Endoscopic Sleeve Gastroplasty - Belt

Sponsor

Brigham and Women's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, Kenya

Study ID: NCT06790342
Start Date: 2026-06-01
End Date: 2030-02-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

Cystine

Positively Smoke Free

Placebo

Standard of Care

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Mobile Health Management of Hypertension

Study ID: NCT05856955
Start Date: 2027-09
End Date: 2028-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

mHealth Coaching Intervention

Enhanced Usual Care

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Study ID: NCT07327229
Start Date: 2026-03-01
End Date: 2029-04-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

132

Intervention / Treatment

ATG-022

Pembrolizumab/KEYTRUDA®

CAPOX

Sponsor

Antengene Biologics Limited

Source: clinicaltrials.gov

Share:
Add to list

Blended Resources for Integrated Diabetes Guidance and Empowerment

Study ID: NCT07373379
Start Date: 2026-03-01
End Date: 2026-10-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

AI-driven Dietary Management and Human-in-the-loop Support

Sponsor

Peking University

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet

Study ID: NCT07374224
Start Date: 2026-03-01
End Date: 2026-08-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

28

Intervention / Treatment

Rocbrutinib tablets

Itraconazole capsules

Rifampicin capsules

Sponsor

Guangzhou Lupeng Pharmaceutical Company LTD.

Source: clinicaltrials.gov

Share:
Add to list

Targeted And Perilesional Or Systematic Biopsy In Prostate Cancer

Study ID: NCT07296042
Start Date: 2026-03
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

456

Intervention / Treatment

Prostate biopsy

Sponsor

Ramsay General Health

Source: clinicaltrials.gov

Share:
Add to list